WINDLAS.BO
Price:
$834.95
Market Cap:
$17.43B
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. The company was incorporated in 2001 and is based in Gurugram, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-08-16
Stock Exchange
BSE
Ticker
WINDLAS.BO
According to Windlas Biotech Limited’s latest financial reports and current stock price. The company's current PE Ratio is 27.13. This represents a change of -10.95% compared to the average of 30.47 of the last 4 quarters.
The mean historical PE Ratio of Windlas Biotech Limited over the last ten years is 30.14. The current 27.13 PE Ratio has changed 8.90% with respect to the historical average. Over the past ten years (40 quarters), WINDLAS.BO's PE Ratio was at its highest in in the March 2020 quarter at 407.63. The PE Ratio was at its lowest in in the June 2020 quarter at -15.73.
Average
30.14
Median
27.07
Minimum
11.30
Maximum
57.70
Discovering the peaks and valleys of Windlas Biotech Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 229.03%
Maximum Annual PE Ratio = 57.70
Minimum Annual Increase = -75.91%
Minimum Annual PE Ratio = 11.30
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 34.82 | 80.24% |
| 2024 | 19.32 | 68.94% |
| 2023 | 11.44 | 1.17% |
| 2022 | 11.30 | -75.88% |
| 2021 | 46.86 | 2.43% |
| 2020 | 45.75 | 229.03% |
| 2019 | 13.90 | -75.91% |
The current PE Ratio of Windlas Biotech Limited (WINDLAS.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
21.86
5-year avg
24.75
10-year avg
30.14
Windlas Biotech Limited’s PE Ratio is less than Amrutanjan Health Care Limited (38.09), less than Amrutanjan Health Care Limited (38.09), greater than Novartis India Limited (20.29), greater than Syncom Formulations (India) Limited (21.75), greater than Syncom Formulations (India) Limited (21.75), greater than Bliss GVS Pharma Limited (16.45), greater than Bliss GVS Pharma Limited (16.45), less than Bajaj HealthCare Limited (31.96), less than Bajaj HealthCare Limited (31.96), greater than Megasoft Limited (12.17),
| Company | PE Ratio | Market cap |
|---|---|---|
| 38.09 | $20.75B | |
| 38.09 | $20.75B | |
| 20.29 | $20.86B | |
| 21.75 | $15.66B | |
| 21.75 | $15.69B | |
| 16.45 | $17.58B | |
| 16.45 | $17.66B | |
| 31.96 | $14.10B | |
| 31.96 | $14.10B | |
| 12.17 | $14.83B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Windlas Biotech Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Windlas Biotech Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Windlas Biotech Limited's PE Ratio?
How is the PE Ratio calculated for Windlas Biotech Limited (WINDLAS.BO)?
What is the highest PE Ratio for Windlas Biotech Limited (WINDLAS.BO)?
What is the 3-year average PE Ratio for Windlas Biotech Limited (WINDLAS.BO)?
What is the 5-year average PE Ratio for Windlas Biotech Limited (WINDLAS.BO)?
How does the current PE Ratio for Windlas Biotech Limited (WINDLAS.BO) compare to its historical average?